ライフサイエンスコーパス: adenoviral

1 ium of Neuro-2A cells or intracellularly via adenoviral 7B2 overexpression, blocked the neurocytotoxi

2 We sought to modify adenoviral (Ad) particles by incorporating the advantage

3 We used an adenoviral (Ad) vector that encodes cyclin-dependent kin

4 We used an adenoviral (Ad) vector to overexpress IGF-II in isolated

5 For adenoviral (Ad) vector-mediated gene transfer and therap

6 aged mice were also injected with attenuated adenoviral adiponectin (Ad-Adn) or Ad-LacZ for 2 wk.

7 selected and cloned into nonhuman Great Ape Adenoviral and Modified Vaccinia Ankara vectors to gener

8 To increase efficiency, we administered adenoviral Apc TALENs and found that we could achieve a

9 Adenoviral B2R overexpression enhanced in vivo vascular

10 The new adenoviral-based in vitro technique did detect, however,

11 We conclude that adenoviral-based studies in primary gonadotropes can ade

12 on, squirrel monkeys given ICV injections of adenoviral BDNF/noggin showed similar addition of striat

13 hat ruxolitinib-exposed mice exhibit delayed adenoviral clearance.

14 prevalence and serotype characterization of adenoviral conjunctivitis in hospital employees.

15 No healthcare-associated adenoviral conjunctivitis outbreaks occurred after algor

16 -office test can prevent the misdiagnosis of adenoviral conjunctivitis that leads to the spread of di

17 Hopkins Hospital with signs and symptoms of adenoviral conjunctivitis underwent evaluation by nurse

18 oPlus is sensitive and specific at detecting adenoviral conjunctivitis.

19 oPlus were assessed for identifying cases of adenoviral conjunctivitis.

20 then randomized to targeted injection of an adenoviral construct (10 muL; 8x10(9) plaque forming uni

21 The adenoviral constructs contained -2871 bp, -750 bp or -23

22 e present study, injections of Cre-dependent adenoviral constructs were targeted to the ventrolateral

23 v/Wv mice by either intrabursal injection of adenoviral Cre or inclusion of the MISR2-Cre transgene a

24 Accordingly, adenoviral Cre recombinase (AdCre)-treated LSL-Kras/Irs-

25 KRAS(G12D) in the lung by nasal delivery of adenoviral Cre recombinase (Cre), here we show that KRAS

26 atients is modelled by confined injection of adenoviral Cre recombinase.

27 ograde pancreatic ductal injection of either adenoviral-Cre or lentiviral-Cre vectors allows titratab

28 n lung cells by intratracheal infection with adenoviral-Cre particles generated hyperplasias in all r

29 Adenoviral-Cre treatment of normal mesothelial cells fro

30 rocyte cultures where Hdac7 was deleted with adenoviral-Cre.

31 We tested the all-in-one adenoviral CRISPR-Cas9 in a circadian clock model cell l

32 In the present study, the adenoviral CRISPR/Cas9 vector was directly injected into

33 Increasing nuclear abundance of p27(kip1) by adenoviral delivery decreases the proliferative response

34 ression or downregulation was achieved using adenoviral delivery of CADM1 short hairpin RNAs or isofo

35 Tumorigenesis was triggered by intravenous adenoviral delivery of Cre recombinase in transgenic mic

36 We determined as a proof-of-principle that adenoviral delivery of CRISPR/Cas9 is capable of correct

37 Adenoviral delivery of GcgR to GcgR(-/-),LepR(-/-) mice

38 Adenoviral delivery of hepcidin to mice attenuates liver

39 ortality during hyperoxia, and lung-targeted adenoviral delivery of Hsp70 effectively rescues both Hs

40 e pulmonary disease airway disease utilizing adenoviral delivery of IL-1beta to determine that adapti

41 pecific goal of the study was to evaluate if adenoviral delivery of LOXL2 is anabolic to human and mo

42 at HDACIs enhance MDA-7/IL-24 lethality, and adenoviral delivery of mda-7/IL-24 combined with tumor-s

43 thod is described to augment the efficacy of adenoviral delivery of mda-7/IL-24 in these cells.

44 Finally, adenoviral delivery of PGC-1alpha into skeletal muscle o

45 These results demonstrate that adenoviral delivery of reprogramming factors and CRISPR/

46 sponse to VEGF, administered via intradermal adenoviral delivery or through systemic injection of rec

47 The overexpression of Btg2 using an adenoviral delivery system elevated FGF21 production by

48 f using a KSHV LANA-targeted CRISPR-Cas9 and adenoviral delivery system to disrupt KSHV latency in in

49 In this study, we designed an adenoviral delivery system to genetically modify hMPCs t

50 We used adenoviral delivery to express full-length wild type or

51 This strategy uses an adenoviral detection system that is shown to successfull

52 ural and nonstructural proteins, can prevent adenoviral dissemination and provide a novel method to m

53 onors with consequent variable prevention of adenoviral dissemination.

54 observed that endothelial cells responded to adenoviral DNA by phosphorylation of ATM and CHK2 and th

55 of DNA damage that can also be activated by adenoviral DNA, and on IRF1, a transcriptional regulator

56 s decreased in ApoER2(-/-) mice, and whereas adenoviral-driven apoE3 expression in wild-type mice has

57 efine a novel function of the antiapoptotic, adenoviral E1B 19K protein that may limit local host inn

58 The adenoviral E1B-55K protein prevents entry into mitosis.

59 The adenoviral E4orf3 protein facilitates exit from mitosis,

60 Thus, degradation of Tip60 by the adenoviral early proteins is important for efficient vir

61 r cells expressing MDA-7/IL-24, in which the adenoviral early region 1A (E1A) gene was driven by the

62 ed induced pluripotent stem cells and during adenoviral editing of mice, paving the way for in situ o

63 By use of a adenoviral eIF5A shRNA, we have achieved an effective de

64 Adenoviral expression of a constitutively active mutant

65 pharmacological inhibitor BI-D1870 or after adenoviral expression of a dominant negative RSK1 mutant

66 f ischemic skin flaps, which was reversed by adenoviral expression of ANKRD1, and delayed excisional

67 Adenoviral expression of Atoh1 or Atoh1 + Gfi1 in cochle

68 prevented in cultured human chondrocytes by adenoviral expression of catalase targeted to the mitoch

69 ion of a CF airway cell line (CF15 cells) by adenoviral expression of CFTR reduced the activation of

70 In this study, adenoviral expression of cMyBP-C(C10mut) in cultured adu

71 n and increased BK-beta1 expression, whereas adenoviral expression of MuRF1 in mouse coronary arterie

72 VEGF neutralization in mice, accomplished by adenoviral expression of soluble Flt1, resulted in 7-fol

73 in vivo attenuation of caspase activity via adenoviral expression of the biologic effector caspase i

74 However, adenoviral expression of WT or constitutively active Fox

75 Adenoviral expression of ZnT2 in lactating mouse mammary

76 d in Zmiz2(-/-) MEFs that were infected with adenoviral expression vectors for Zmiz2.

77 Initial attachment occurs via the adenoviral fibre knob protein and a cellular receptor.

78 liver 5 x 10(13) total viral particles of an Adenoviral firefly luciferase vector with a cytomegalovi

79 ng cultured neonatal rat cardiomyocytes with adenoviral gene delivery and pharmacological inhibitors,

80 hMPCs in an in vivo model, the safety of the adenoviral gene delivery was evaluated.

81 Adenoviral gene delivery was shown to be safe, with no d

82 lational block when used in combination with adenoviral gene delivery.

83 ad candidates for their capacity to increase adenoviral gene expression in an orthotopic in vivo mode

84 irst time that cationic polymers can enhance adenoviral gene expression in an orthotopic model of bla

85 o determine if cationic polymers can enhance adenoviral gene expression in cells that are difficult t

86 polymer NPGDE-1,4 Bis significantly enhanced adenoviral gene expression in the orthotopic model of bl

87 ide-based polymer paromomycin-BGDE, enhanced adenoviral gene expression within the bladder without ad

88 ly, further overexpression of vasohibin-1 by adenoviral gene transfer exerts multifold beneficial eff

89 Adenoviral gene transfer of a single-chain IL-23 induces

90 The adenoviral gene transfer of human aquaporin-1 (hAQP1) wa

91 cyte canalicular expression of hAQP1 through adenoviral gene transfer promotes biliary BS output by m

92 pacing, and are amenable to patch clamp and adenoviral gene transfer techniques.

93 Using adenoviral gene transfer, wild-type and mutant SK2 chann

94 owing heterologous expression in myocytes by adenoviral gene transfer, wild-type telethonin became bi

95 The inactivation rate corresponding to adenoviral genome damage matched the inactivation rate o

96 E1A expression translates into inhibition of adenoviral genome replication, infectious particle produ

97 Nuclear delivery of the adenoviral genome requires that the capsid cross the lim

98 Adenoviral Glrx-induced sFlt in EC was inhibited by a co

99 postsynaptic GluA2-lacking AMPA receptors in adenoviral GluA1-infected CeA neurons.

100 Recent work has shown that helper-dependent adenoviral (hdAD) vector-mediated plasma CocH reduced th

101 Furthermore, adenoviral hSCF treatment in wild-type cardiomyocytes si

102 using ROSA(mTmG);Wt1(CreER) mice showed that adenoviral hSCF treatment increased Wt1(+) lineage-deriv

103 In cultured EPDCs, adenoviral hSCF treatment significantly increased cell p

104 une responses to HAdV.IMPORTANCE An emergent adenoviral human pathogen, HAdV-B76, associated with a f

105 DC chemokine receptor ccr6 both protect from adenoviral IL-1beta-induced airway adaptive T cell immun

106 e insertion of artificial aptazymes into the adenoviral immediate early gene E1A enables small-molecu

107 tivity and PCR were employed to quantify the adenoviral inactivation rates using narrow bands of irra

108 Consistent with these findings, adenoviral-induced Pim-1 neonatal rat cardiomyocytes (NR

109 Specifically, we demonstrated that adenoviral induction of prolymphangiogenic factor VEGF-C

110 One patient died from an overwhelming adenoviral infection before reconstitution with genetica

111 humans; however, prior exposure from natural adenoviral infection can decrease such responses.

112 Adenoviral infection induced inflammatory infiltrates pr

113 In an adenoviral infection model, such CTL contained the early

114 Finally, using an adenoviral infection model, we show that ruxolitinib-exp

115 ed using its specific inhibitor AS1842856 or adenoviral infection of constitutively active FOXO1.

116 inducing reactive oxygen species (ROS) after adenoviral infection of mda-7/IL-24 leads to greater tra

117 Reconstitution of ANKRD1 by adenoviral infection stimulated both collagen gel contra

118 imental murine AIH (emAIH) by a self-limited adenoviral infection with the hepatic autoantigen formim

119 Using adenoviral infection, a ratiometric mitochondrially targ

120 /2 phosphorylation remained unchanged during adenoviral infection, suggesting specificity of JNK acti

121 ion was induced at a magnitude comparable to adenoviral infection, suggesting that AQP1 is primarily

122 totic or a nonapoptotic death as a result of adenoviral infection.

123 es of graft failure, cytomegalovirus, and/or adenoviral infections and transplant-related mortality a

124 stream pathways mediate these Ito,f changes, adenoviral infections were used to inhibit CaMKIIdeltac,

125 ical outcome of both natural and therapeutic adenoviral infections.

126 Adenoviral injection of active TGF-beta1 into the anteri

127 siRNA; affecting FGFR3-IIIb and -IIIc) or an adenoviral kinase-dead FGFR3-IIIc construct (kdFGFR3).

128 Adenoviral knockdown of CeA GluA2 subunits facilitated C

129 Adenoviral L-Fabp transduction inhibited activation of p

130 as applied as an imaging reporter to monitor adenoviral liver transduction with both nuclear and opti

131 Adenoviral-mediated DAPK2 overexpression in 3T3-L1 adipo

132 protected from pulmonary fibrosis induced by adenoviral-mediated expression of active TGF-beta1.

133 ty and pain in a model of cystitis caused by adenoviral-mediated expression of claudin-2 (Cldn2), a t

134 Effects of vasohibin-1 overexpression by adenoviral-mediated gene transfer on angiogenesis, fibro

135 xtent similar to isoproterenol exposure, and adenoviral-mediated knockdown of Epac1 prevented isoprot

136 Following adenoviral-mediated overexpression of SOD2 activity (5-7

137 Increasing HO-1 expression through adenoviral-mediated overexpression or induction with cob

138 We therefore tested the effects of adenoviral-mediated overexpression or small interfering

139 othelial monolayers, which was reversible by adenoviral-mediated PICALM transfer.

140 We show that adenoviral-mediated silencing of hepatic Fsp27 abolishes

141 e role of versican, a vitreous component, in adenoviral-mediated transgene expression was examined.

142 The effects of adenoviral mitofusin-2 (Ad-MFN2) overexpression were mea

143 We used our adenoviral model of memory inflation to first investigat

144 ergoing HCV vaccination with recombinant HCV adenoviral/modified vaccinia Ankara viral vectors.

145 NF-kappaB activation involve infection of an adenoviral NF-kappaB-luciferase reporter into cell lines

146 We have previously shown that adenoviral or transgenic overexpression of human CD81 an

147 Adenoviral over-expression of Atoh1 and Gfi1 in cultured

148 Adenoviral over-expression of DUSP1 inactivated MAPK pat

149 Adenoviral overexpression of ApoM in Apom(-/-) mice decr

150 Adenoviral overexpression of beta3-AR in isolated cardia

151 This reduced expression was not restored by adenoviral overexpression of BiP (immunoglobulin-binding

152 Adenoviral overexpression of CLIC4 in cultured human pul

153 d endothelial cells, metformin treatment and adenoviral overexpression of constitutively active AMPK

154 Indeed, adenoviral overexpression of cytoplasmic SRF (SRF-DeltaN

155 on was impaired in CREBH-deficient mice, and adenoviral overexpression of FGF21 suppressed adipose ti

156 Adenoviral overexpression of GluA1 subunits in CeA accel

157 e decreased the vascular leakage compared to adenoviral overexpression of green fluorescent protein.

158 In vitro, adenoviral overexpression of miR-24 targets lacking miR-

159 Using therapeutic silencing of miR-33 and adenoviral overexpression of miR-33, we show that miR-33

160 gely non-amyloidogenic degradation products, adenoviral overexpression of MMP-9 in amyloid-prone isle

161 Importantly, adenoviral overexpression of neprilysin in islets cultur

162 Adenoviral overexpression of osteoglycin in wild-type mi

163 In osteoglycin null mice, adenoviral overexpression of osteoglycin was unable to p

164 Accordingly, adenoviral overexpression of Rab5 or D52 enhanced secret

165 In vivo adenoviral overexpression of RARbeta in the liver enhanc

166 t3 ablation sensitized mice to NASH, whereas adenoviral overexpression of Sirt3 alleviated the NASH p

167 Adenoviral overexpression of Smad2 also blocked SLPI-ind

168 Adenoviral overexpression of SMILE (Ad-SMILE) attenuated

169 Conversely, adenoviral overexpression of TXNIP abrogated the restora

170 We used an adenoviral overexpression strategy to show that both ful

171 Through a series of genetic silencing and adenoviral overexpression studies, we have defined GLUT1

172 parent absence and then reemergence of human adenoviral pathogens, as well as present pathways for th

173 significant roles in the emergence of human adenoviral pathogens.

174 h the PLD product, phosphatidic acid (PA) or adenoviral PLD1 expression in Pld1(-/-) hepatocytes, con

175 infection, since this population is naive to adenoviral preformed immunity.

176 er proteins, maturational proteolysis by the adenoviral protease leads to the differential release of

177 nhanced inactivation at low wavelengths with adenoviral protein damage at those wavelengths, adding f

178 define a new function of the antiapoptotic, adenoviral protein E1B 19K, which we have termed "apopto

179 Gam1 is an adenoviral protein, which also possesses a BC-box domain

180 This research shows UV-induced damage to adenoviral proteins across the germicidal UV spectrum at

181 is and by promoting exit from mitosis, these adenoviral proteins act to prevent the infected cell fro

182 Early adenoviral proteins, including the E1B-55K and E4orf3 pr

183 To identify those APCs, we used adenoviral (rAd) vectors, which do not infect DCs but se

184 Replication-competent adenoviral (RC-Ad) vectors generate exceptionally strong

185 Additionally, the presence of a critical adenoviral replication element found in HAdV genomes, in

186 early cytokine production is independent of adenoviral replication.

187 identified several candidates that enhanced adenoviral reporter gene expression in vitro.

188 Using gene deletion and adenoviral rescue, we demonstrate that both the GEF (CDC

189 While m(6)A-modified adenoviral RNAs have been previously detected, the locat

190 and the immunity induced by the recombinant adenoviral RSV vaccine administered by use of an intramu

191 Human adenoviral serotype 5 (HAdV-5) vectors have predominantl

192 Fourteen of the 44 employees had adenoviral serotypes and clinical presentation consisten

193 Importantly, acute hepatic knockdown by adenoviral shRNA targeting G9a abolishes Fgf21 repressio

194 TRAF2 knockdown with adenoviral shRNA transduction induces accumulation of de

195 Adenoviral shRNA-mediated downregulation of CeA GluA1 pr

196 ither Bmal1 deficiency or Bmal1 depletion by adenoviral shRNA.

197 ators, we depleted these co-activators using adenoviral shRNAs.

198 Finally, knockdown of DIC with adenoviral siRNA also rendered CGNs more susceptible to

199 We implanted adenoviral SkM1, HCN2, or HCN2/SkM1 constructs into left

200 t examinations should take measures to avoid adenoviral spread from contaminated handheld equipment.

201 ich is required for efficient cell lysis and adenoviral spread.

202 Furthermore, overexpression of miR-133b via adenoviral system in vitro led to decreased CTGF express

203 In addition, both recombinant and adenoviral TGF-beta3 significantly promoted epithelial-t

204 r497/495 was reversed by micro-calpsiRNA and adenoviral transduced dominant negative protein kinase C

205 Adenoviral transduction allowed TIMP3 overexpression.

206 ukocytes from 112 Hispanic patients by using adenoviral transduction and 24-h culture, with quantitat

207 Adenoviral transduction of NPCs with a kinase-defective

208 In conclusion, we show that adenoviral transduction stimulates IL-33 expression in e

209 ression of desmin or vimentin was induced by adenoviral transduction to examine the sufficiency of in

210 We overcame this obstacle through in vivo adenoviral transduction with matrix-targeted photoactiva

211 3 expression was stimulated as a response to adenoviral transduction.

212 In vivo adenoviral transfection of KLF2 to the carotid bodies in

213 d through transgenic overexpression of TFF2, adenoviral transfer of TFF2 or transplantation of TFF2-e

214 and prolonged following vaccination with an adenoviral vaccine encoding GP linked to Ii compared wit

215 We developed potential adenoviral vaccines that express a fusion protein of HPV

216 al trials, underlying the need for improving adenoviral vaccines-induced immunogenicity.

217 the lymphatic network in the defected area, adenoviral vascular endothelial growth factor C (VEGF-C)

218 clones, gene correction by helper-dependent adenoviral vector (HDAdV) or Transcription Activator-Lik

219 er vaccination with a rhesus macaque-derived adenoviral vector (simian adenovirus 7 [SAdV-7]) enhance

220 when delivered with a replication-defective adenoviral vector [Ad5-poIRF7/3(5D)].

221 rus receptor (sCAR-Fc) was expressed from an adenoviral vector and 2 short hairpin RNAs (shRdRp2.4) d

222 A vaccine platform transduced with the adenoviral vector and loaded in tandem with the recombin

223 An adenoviral vector containing human SPARC was used to inc

224 nfection strategies and provide insights for adenoviral vector development and structure-based design

225 thway, rats were intravenously injected with adenoviral vector encoding a decoy VEGF receptor (Ad-Flk

226 ritic cells transduced with the adjuvant, an adenoviral vector encoding a dominant negative isoform o

227 Intranodally injected adenoviral VEGF-C and adenoviral vector encoding control gene LacZ induced mac

228 neural targets of the VMHdm by injecting an adenoviral vector encoding Cre recombinase (Cre)-regulat

229 e demonstrated that intratumoral delivery of adenoviral vector encoding single-chain (sc)IL-23 (Ad.sc

230 lymphoblastoid cell lines transduced with an adenoviral vector expressing either LMP2 alone (n = 17)

231 genital administration of an IL-4-expressing adenoviral vector greatly increased in vivo ESC prolifer

232 Mice that expressed VEGFC from the adenoviral vector had increased lymphatic vessel density

233 er vaccination with a rhesus macaque-derived adenoviral vector in rhesus macaques enhances mucosal CD

234 The results showed that vaccination with an adenoviral vector indeed increases activation of mucosal

235 We found that a chimeric adenoviral vector overcame the inherent resistance of pr

236 o/fl) and Flna (o/fl)/ LC mice with AdPCSK9 (adenoviral vector overexpressing proprotein convertase s

237 that a genetically engineered RSV-F-encoding adenoviral vector provides protective immunity against R

238 cancer cell line (HT29) transfected with an adenoviral vector that expressed Ad VP16hLXRalpha, compa

239 ght on this, we developed a helper-dependent adenoviral vector that expresses the genetically encoded

240 This trial used a prototype adenoviral vector to express aquaporin-1 (AQP1), presuma

241 Specifically, mice treated with an adenoviral vector to overexpress IFN-lambda during influ

242 in preBotC astrocytes bilaterally (using an adenoviral vector to specifically express tetanus toxin

243 perfusion strategy, optimized for efficient Adenoviral vector transduction, was utilized to deliver

244 hese data implicate versican G1 in enhancing adenoviral vector transgene expression in a hyaluronic a

245 intracerebroventricular (ICV) delivery in an adenoviral vector triggers the addition of new neurons t

246 In addition, the adenoviral vector was not integrated into the genome of

247 Therefore, we created a helper-dependent adenoviral vector with the mitochondria-targeting peroxi

248 often retain wild type p53, we developed an adenoviral vector, AdRGD-PG, which provides robust trans

249 Using RNAi and a new generation of adenoviral vector, we have silenced hepatic SREBP-1 in n

250 Adenoviral vector-mediated in vivo transduction was used

251 was overexpressed in SIRT1 LKO mice using an adenoviral vector.

252 ter vaccination with a replication-deficient adenoviral vector.

253 ially created N- and C-terminal-tagged Luman adenoviral vector.

254 by infecting cells with a p220 cDNA-encoding adenoviral vector.

255 ose of ChAdOx1 MERS, a replication-deficient adenoviral vectored vaccine expressing MERS-CoV spike pr

256 Vaccination with potent HCV adenoviral vectored vaccines fails to restore T-cell imm

257 patients were vaccinated using heterologous adenoviral vectors (ChAd3-NSmut and Ad6-NSmut) encoding

258 Recombinant adenoviral vectors (rAds) are lead vaccine candidates fo

259 Recombinant adenoviral vectors (rAds) are the most potent recombinan

260 ssed and CD63 was knocked down in mice using adenoviral vectors AdTIMP1 or AdshCD63, respectively.

261 t liver detargeting and tumor retargeting of adenoviral vectors after coating with synthetic dendrime

262 Adenoviral vectors are being developed as vaccines again

263 Adenoviral vectors can induce T and B cell immune respon

264 n astrocytes of mouse cortex by injection of adenoviral vectors containing a strong and astrocyte-spe

265 Adenoviral vectors encoding hepatitis C virus (HCV) nons

266 ly reduced by cotreatment with sorafenib and adenoviral vectors encoding hOCT1 under the control of t

267 in vitro experiments with HSCs infected with adenoviral vectors encoding LacZ, Dyn2K44A, or Dyn2WT.

268 B/c (L. monocytogenes-susceptible) mice with adenoviral vectors encoding natural L. monocytogenes-der

269 ion of XBP1 was knocked down by injection of adenoviral vectors encoding small hairpin RNAs against X

270 his effect was enhanced by co-treatment with adenoviral vectors encoding SOX17.

271 and why this is so, we have generated potent adenoviral vectors encoding the endogenous tumor Ags (TA

272 Prophylactic vaccination with adenoviral vectors expressing either TRP-2 (Ad-Ii-TRP-2)

273 In protocol A, we injected adenoviral vectors expressing TBX18 (or the reporter con

274 ERS-CoV infection by prior transduction with adenoviral vectors expressing the human host-cell recept

275 xpressing Cyclo-oxygenase-2 by 600-fold, and adenoviral vectors expressing the pro-apoptotic gene Bax

276 o overcome these hurdles in order to develop adenoviral vectors for combination of systemic oncolytic

277 antibodies, which can selectively immobilize adenoviral vectors for gene delivery of growth factors.

278 optimization and development of HAdV-5-based adenoviral vectors for gene therapy.

279 Adenoviral vectors have long been forerunners in the dev

280 SK-N-DZ neuroblastoma cells transduced with adenoviral vectors in the presence of versican respond w

281 Chronic central administration of MCH and adenoviral vectors increasing MCH signaling were perform

282 nd suggest that E1B 19K-deleted, replicating adenoviral vectors might induce greater inflammatory res

283 king the kappa opioid receptor (kappaOR) and adenoviral vectors overexpressing or silencing kappaOR w

284 Treatment efficacy of the adenoviral vectors released from the MMP responsive SELP

285 Here we discuss the unique features of adenoviral vectors that enable tissue specific and effic

286 lymphocytic choriomeningitis virus model and adenoviral vectors to compare a vaccine expressing unmod

287 We used adenoviral vectors to express Nor-1 in normal liver (Ad/

288 lls (HUVEC) were transduced with recombinant adenoviral vectors to express wild-type, constitutively

289 Adenoviral vectors were used to induce transient overexp

290 induced by the brain delivery of recombinant adenoviral vectors with neuronal-specific expression of

291 Importantly, via its compatibility with adenoviral vectors, pMAGIC uniquely enables use of dCas9

292 nt8a, Wnt16, and WISP1 in the synovium using adenoviral vectors.

293 e T cell responses to tethered Ag encoded in adenoviral vectors.

294 CD80/86 for efficient CD8 T cell priming by adenoviral vectors.

295 9 RNA-guided nucleases, and helper-dependent adenoviral vectors.

296 ted efficiently with replication-incompetent adenoviral vectors.

297 Intranodally injected adenoviral VEGF-C and adenoviral vector encoding control

298 ii) ear angiogenic responses to intradermal adenoviral-VEGF injection, and iii) vascular flow recove

299 tivation profiles and binding affinities for adenoviral virus-associated RNA I (VA RNAI) and HIV-1 tr

300 Transduction of GCs with the dephospho-adenoviral-YB-1(S102A) mutant prevented the induction by